| A small molecule transcription factor EB activator ameliorates beta‐amyloid precursor protein and Tau pathology in Alzheimer's disease models JX Song, S Malampati, Y Zeng, SSK Durairajan, CB Yang, BCK Tong, ... Aging cell 19 (2), e13069, 2020 | 119 | 2020 |
| Neurogenic traditional Chinese medicine as a promising strategy for the treatment of Alzheimer’s disease SG Sreenivasmurthy, JY Liu, JX Song, CB Yang, S Malampati, ZY Wang, ... International Journal of Molecular Sciences 18 (2), 272, 2017 | 57 | 2017 |
| Neuroprotective natural products for the treatment of Parkinson's disease by targeting the autophagy–lysosome pathway: A systematic review ZY Wang, JY Liu, CB Yang, S Malampati, YY Huang, MX Li, M Li, JX Song Phytotherapy Research 31 (8), 1119-1127, 2017 | 48 | 2017 |
| A curcumin derivative activates TFEB and protects against parkinsonian neurotoxicity in vitro Z Wang, C Yang, J Liu, B Chun-Kit Tong, Z Zhu, S Malampati, ... International journal of molecular sciences 21 (4), 1515, 2020 | 47 | 2020 |
| Targeting aggrephagy for the treatment of Alzheimer’s disease S Malampati, JX Song, B Chun-Kit Tong, A Nalluri, CB Yang, Z Wang, ... Cells 9 (2), 311, 2020 | 46 | 2020 |
| Protective Effect of Bioactivity Guided Fractions of Ziziphus jujuba Mill. Root Bark against Hepatic Injury and Chronic Inflammation via Inhibiting Inflammatory … R Kandimalla, S Dash, S Kalita, B Choudhury, S Malampati, K Kalita, ... Frontiers in pharmacology 7, 298, 2016 | 36 | 2016 |
| A comparative effect of atorvastatin with other statins in patients of hyperlipidemia MA Jose, S Anandkumar, MP Narmadha, M Sandeep Indian Journal of Pharmacology 44 (2), 261, 2012 | 36 | 2012 |
| Protopine promotes the proteasomal degradation of pathological tau in Alzheimer's disease models via HDAC6 inhibition SG Sreenivasmurthy, A Iyaswamy, S Krishnamoorthi, S Senapati, ... Phytomedicine 96, 153887, 2022 | 35 | 2022 |
| Lysosomal TPCN (two pore segment channel) inhibition ameliorates beta-amyloid pathology and mitigates memory impairment in Alzheimer disease BCK Tong, AJ Wu, AS Huang, R Dong, S Malampati, A Iyaswamy, ... Autophagy 18 (3), 624-642, 2022 | 34 | 2022 |
| NeuroDefend, a novel Chinese medicine, attenuates amyloid-β and tau pathology in experimental Alzheimer's disease models A Iyaswamy, SK Krishnamoorthi, JX Song, CB Yang, V Kaliyamoorthy, ... Journal of food and drug analysis 28 (1), 132-146, 2020 | 32 | 2020 |
| A modified formulation of Huanglian-Jie-Du-Tang reduces memory impairments and β-amyloid plaques in a triple transgenic mouse model of Alzheimer’s disease SSK Durairajan, A Iyaswamy, SG Shetty, AK Kammella, S Malampati, ... Scientific reports 7 (1), 6238, 2017 | 30 | 2017 |
| Yuan-Hu Zhi tong prescription mitigates tau pathology and alleviates memory deficiency in the preclinical models of Alzheimer’s Disease A Iyaswamy, JX Song, AK Kammala, SG Sreenivasmurthy, S Malampati, ... Frontiers in Pharmacology 11, 584770, 2020 | 24 | 2020 |
| Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration Y Jiang, JJ Alam, SN Gomperts, P Maruff, AW Lemstra, UA Germann, ... Nature communications 13 (1), 5308, 2022 | 23 | 2022 |
| Bioactive Fraction of Annona reticulata Bark (or) Ziziphus jujuba Root Bark along with Insulin Attenuates Painful Diabetic Neuropathy through Inhibiting NF-κB … R Kandimalla, S Dash, S Kalita, B Choudhury, S Malampati, R Devi, ... Frontiers in cellular neuroscience 11, 73, 2017 | 23 | 2017 |
| Bioactive Guided Fractions of Annona reticulata L. bark: Protection against Liver Toxicity and Inflammation through Inhibiting Oxidative Stress and Proinflammatory … R Kandimalla, S Dash, S Kalita, B Choudhury, S Malampati, K Kalita, ... Frontiers in pharmacology 7, 168, 2016 | 21 | 2016 |
| Decrease in the generation of amyloid-β due to salvianolic acid B by modulating BACE1 activity S Sundara Kumar Durairajan, V Reddy Chirasani, ... Current Alzheimer Research 14 (11), 1229-1237, 2017 | 16 | 2017 |
| Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease NM Kulkarni, S Malampati, MYA Mahat, S Chandrasekaran, J Raghul, ... Drug metabolism and personalized therapy 31 (3), 165-171, 2016 | 13 | 2016 |
| Prenatal and developmental toxicity study of meclizine and caffeine combination in female albino Wistar rats M Sandeep, AM Jose NISCAIR-CSIR, India, 2014 | 2 | 2014 |
| TFEB activator C1 ameliorates app and tau pathology and rescues cognitive deficits in neurodegenerative diseases M Li, S Juxian, S Malampati US Patent 10,987,319, 2021 | | 2021 |
| Modified Huang-lian-Jie-Du-tang and its combination with memantine for alzheimer disease: an in vivo study (abridged secondary SSK Durairajan, M Li, SK Chung, QB Han, A Iyaswamy, ... Hong Kong Med J 26 (6 Supplement 7), 2020 | | 2020 |
